Express Pharma

APRIL 7, 2025

Factors driving the growth of FDCs One of the primary reasons for the rise of FDCs has been their role in addressing diseases that require multi-drug therapy, such as tuberculosis, cardiovascular conditions, diabetes, and infectious diseases. Rifampicin + Isoniazid + Ethambutol) Antimalarial combinations (e.g.,

Diabetes 66

Diabetes Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 66

Express Pharma

SEPTEMBER 6, 2023

According to the World Health Organisation (WHO), an estimated two billion people across the world do not have access to essential medicines for life threatening diseases like cancer, AIDS and even autoimmune diseases like Type 1 diabetes.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing 59

Express Pharma

NOVEMBER 1, 2024

The FDA’s 505(b)(2) pathway and the European Medicines Agency’s (EMA) Hybrid Pathway offer routes for drug developers to rely on previously submitted clinical data, cutting down approval times significantly. As the world’s largest manufacturer of generic medicines, India has vast potential to utilise repurposed drugs.

Drug Development 111

Drug Development Compounding Generic Medicine Vaccines 111

Quality Matters

OCTOBER 13, 2021

Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient. Starting in 2018, the presence of nitrosamine impurities was identified in some angiotensin II receptor blockers (ARBs) used to treat high blood pressure and heart failure.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding 52